Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LUMEN-Dx: Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer

NCT06963307 is registered in ClinicalTrials.gov with JaxBio Ltd as lead sponsor.

NCT NCT06963307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06963307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LUMEN-Dx: Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer
Lead sponsor
JaxBio Ltd
Phase
Observational
Overall status
Recruiting
Start date
May 31, 2025
Completion date
November 30, 2026
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, non-small cell